AGTC Announces Sponsorship of Achroma Corp’s No Roadblocks Program
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, announced it will be a sponsor of the Achroma Corp program, No Roadblocks.
Tampa’s Morphogenesis Wants To Cure Cancer With an Affordable Shot
A group of scientists in Tampa is working to make treating cancer as easy as getting a shot. While most of today's cancer treatments tend to be toxic and expensive, UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage biotechnology company, is working to develop immunotherapies that are safe and affordable.
UF Innovate Welcomes Lauren Asmus as Client Experience Manager
UF Innovate | Incubation Services is delighted to welcome Lauren Asmus as the program’s first Client Experience Manager. Lauren joined the team on August 16 and will serve clients and implement entrepreneurial programs at UF Innovate | Incubation Services’ facilities Sid Martin Biotech and The Hub.
DiaCarta Receives CE/IVD for its New COVID 19 test that Identifies Delta Plus and New Variants
UF Innovate | Sid Martin Biotech alum DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy, announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can now be commercialized within the EU and rest of the world.
Axogen’s Aim: Growing Tampa Into a Hub for Nerve Repair Treatment Technology
As a biotech company at the forefront of nerve repair treatment, UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, has always been near the front of the scientific curve.
Axogen, Inc. Appoints John H. Johnson to Board of Directors
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that John H. Johnson has been appointed to its Board of Directors.
DiaCarta Q&A: Liquid Biopsy for Early Cancer Detection
DiaCarta is initiating a large-scale clinical development program, which will monitor cfDNA levels to determine early treatment outcomes of systemic therapy in all types of stage IV cancer.
RTI Surgical and Exactech Announce Strategic Partnership
UF startup and UF Innovate | Sid Martin Biotech alum RTI Surgical Holdings, Inc., a leading surgical implant company providing blue-chip OEM customers with a portfolio of tissue-based, synthetic and metal implants, has announced it has entered into a long-term strategic agreement with Gainesville-based and leading global medical device OEM Exactech, related to the development and supply of biologic bone substitutes.
Experimental Skin Cancer Vaccine Developed in Tampa Saves Woman’s Life
A vaccine developed by Morphogenesis, Inc., a UF startup and UF Innovate | Sid Martin Biotech alum, helped improve a patients condition.
AGTC Reports 12-Month Data From Its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients With Mutations in the ACHM
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, reported 12-month data from its ongoing achromatopsia (ACHM) Phase 1/2 clinical trials, including data from all adult patients and low-dose pediatric patients.